Re: UTHR presentation today at Oppenheimer extensively covered MNKD's technosphere
MNKD update after again listening to the UTHR presentation and running the numbers. Remember we will also be doing at least $70M next year in Afrezza.
The stock has made several moves over $2, but always pulls back. Unfortunately speculative stocks don't do well when the market is teetering on the edge.
MNKD has presented at 3 different conferences in the last two weeks and their partner UTHR presented yesterday. UTHR praised extensively the technosphere inhaler from MNKD and will use it for hypertension and COPD drugs that they have already approved. These drugs are being trialed and moved from a nebulizer to the MNKD inhaler. Based on projected sales the royalties to MNKD will be $200M-$400M annually. UTHR also mentioned other pulmonary drugs that could use MNKD's inhaler.
MNKD has recently hired several executives from Medtronic's who worked with their closed loop insulin system. The rumor is Medtronic's will take a stake in MNKD for Afrezza their dry powdered inhaled insulin. Ironically UTHR's presentation yesterday mentioned a future partnership with Medtronic.
To me the revenue and entire story is finally coming together. Two big partners and now 3 drugs with more to come on the technosphere inhaler from MNKD. I still think I retire on this stock. Buyer beware I've been pumping this sucker on this board for at least 3 years. Lol